Nanjing Hicin Pharmaceutical Co., Ltd. (SHE:300584)

China · Delayed Price · Currency is CNY

44.55

+0.11 (0.25%)

Feb 4, 2026, 2:55 PM CST

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
Cardiovascular	427.78M
Cardiovascular Growth	18.98%
Antibiotics	37.01M
Antibiotics Growth	-42.07%
Anti-virus	8.74M
Anti-virus Growth	-34.76%
Digestive	8.71M
Digestive Growth	-20.15%
Active Pharmaceutical Ingredients and Intermediates	7.57M
Active Pharmaceutical Ingredients and Intermediates Growth	122.13%
Immunomodulatory	4.51M
Immunomodulatory Growth	56.21%
Other Business	2.25M
Other Business Growth	21.43%
Diuretics	1.62M
Diuretics Growth	-96.03%
Other	6.17M
Other Growth	-70.78%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
China	504.36M
China Growth	-2.60%